Merck & Co Inc (NYSE:MRK)
| 79.45 Delayed Data As of Jan 25 |  -0.01 / -0.01%Today’s Change | 68.38 Today|||52-Week Range 91.40 | +3.67% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 79.46 |
| Today’s open | 78.42 |
| Day’s range | 77.78 - 79.77 |
| Volume | 4,032 |
| Average volume (3 months) | 15,599,363 |
| Market cap | $202.0B |
Data as of 4:00pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | -27.21% |
| Earnings growth (this year) | +2.32% |
| Earnings growth (next 5 years) | +12.50% |
| Revenue growth (last year) | +3.06% |
| P/E ratio | 23.9 |
| Price/Sales | 4.33 |
| Price/Book | 7.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | -0.01 | -0.01% |
| AZNAstraZeneca | +0.88 | +1.54% |
| LLYEli Lilly and Co | -0.18 | -0.08% |
| ABBVAbbVie | +0.03 | +0.02% |
Data as of 4:24pm ET, 01/25/2022
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $1.53 |
| Annual revenue (last year) | $48.0B |
| Annual profit (last year) | $7.1B |
| Net profit margin | 14.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
